Published in Nouv Rev Fr Hematol on December 29, 1975
Increase of endothelial cell growth by sera from diabetic patients with proliferative retinopathy. Lancet (1989) 2.05
Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet (2008) 1.83
Characteristic distribution pattern of Helicobacter pylori in dental plaque and saliva detected with nested PCR. J Med Microbiol (2000) 1.50
Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome. J Clin Invest (1980) 1.45
Respiratory and other hazards of isocyanates. Int Arch Occup Environ Health (1994) 1.36
Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment. Blood Rev (2002) 1.31
Availability of platelet Factor 3 and activation of factor XII in thrombasthenia. Nature (1965) 1.20
Monoclonal antibody to human platelet glycoprotein I. I. Immunological studies. Br J Haematol (1981) 1.18
Artificial and bioartificial liver devices: present and future. Gut (2009) 1.14
Delineation of 15q13.3 microdeletions. Clin Genet (2010) 1.13
Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors. Am J Pathol (1981) 1.11
Binding and endocytosis of heparin by human endothelial cells in culture. Biochim Biophys Acta (1985) 1.11
Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant. N Engl J Med (1986) 1.10
Regulation of calcium accumulation and efflux from platelet vesicles. Possible role for cyclic-AMP-dependent phosphorylation and calmodulin. Biochim Biophys Acta (1983) 1.07
Aggregation, adhesion, and viscous metamorphosis of platelets in congenital fibrinogen deficiencies. J Lab Clin Med (1966) 1.07
Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am J Med (1990) 1.07
The purification performance of infiltration basins fitted with pretreatment facilities: a case study. Water Sci Technol (2001) 1.03
New functions for platelets and their pathological implications. Int Arch Allergy Appl Immunol (1985) 1.03
[Direct stimulation of insulin secretion in vitro by scretion]. Dtsch Med Wochenschr (1965) 1.03
Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. Am J Ind Med (1998) 1.02
Evidence of genetic recombination in wheat yellow rust populations of a Chinese oversummering area. Fungal Genet Biol (2009) 1.00
Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation. Thromb Haemost (1988) 0.99
The capsian escargotieres. Science (1976) 0.98
[Resynthesis of insulin from the preoxidized A chain and reduced B chain]. Justus Liebigs Ann Chem (1966) 0.97
Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His. Blood (1987) 0.97
Thrombocytopenic c-mpl(-/-) mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response. Blood (2001) 0.96
Electron staining with uranyl acetate. Possible role of free amino groups. J Histochem Cytochem (1971) 0.96
[Elastinolytic activity associated with blood platelets]. Pathol Biol (Paris) (1970) 0.95
Increased adhesion to fibronectin and Mo-1 expression by diabetic monocytes. J Immunol (1987) 0.93
[Variations of platelet sialic acid in constitutional and acquired thrombopathies]. C R Acad Sci Hebd Seances Acad Sci D (1971) 0.93
Dramatic change in public attitudes towards vaccination during the 2009 influenza A(H1N1) pandemic in France. Euro Surveill (2013) 0.92
Ameloblastin fusion protein enhances pulpal healing and dentin formation in porcine teeth. Calcif Tissue Int (2006) 0.92
Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. Leukemia (1999) 0.92
Platelet fibrinogen. J Clin Pathol (1965) 0.91
Congenital bleeding disorders with long bleeding time and normal platelet count. II. Von Willebrand's disease (report of thirty-seven patients). Am J Med (1968) 0.91
Ultrastructural localization of DNA in ultrathin tissue sections. Int Rev Cytol (1976) 0.90
[The wild boar of Egypt]. C R Acad Sci III (1999) 0.90
Radiotherapy of macular degeneration. Experience with two fractionation schemes. Front Radiat Ther Oncol (1997) 0.90
Studies on a human blood platelet protease with elastolytic activity. Biochim Biophys Acta (1973) 0.89
New carbohydrate site in mutant antithrombin (7 Ile----Asn) with decreased heparin affinity. FEBS Lett (1988) 0.88
Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser. J Clin Invest (1988) 0.88
The problem of intramuscular haemangioma. Arch Orthop Trauma Surg (1982) 0.87
[Behavior of rat platelets]. Thromb Diath Haemorrh (1966) 0.87
Mandatory immunization: the point of view of the French general population and practitioners. Vaccine (2008) 0.87
Aggregation of human gel-filtered platelets. Requirement of apyrase and proteins. Rev Eur Etud Clin Biol (1972) 0.87
Helicobacter pylori in the oral cavity: high prevalence and great DNA diversity. Dig Dis Sci (2000) 0.87
Investigation of the association of major histocompatibility complex genes, including HLA class I, class II and TAP genes, with clinical forms of Crohn's disease. Eur J Immunogenet (1996) 0.87
Enzymatic activities, ADP-induced aggregation and survival in vivo as criteria of platelet viability during storage. Transfusion (1967) 0.86
Platelet hyperaggregation and increased plasma level of Von Willebrand factor in diabetics with retinopathy. Diabetologia (1975) 0.85
Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities. J Dairy Sci (1993) 0.85
Release of elastolytic activity from blood platelets. Nature (1970) 0.85
Molecular defect in platelets from patients with bernard-soulier syndrome. Blood (1977) 0.84
Determination of platelet antigens and glycoproteins in the human fetus. Blood (1986) 0.84
Association of autoimmune thrombocytopenic purpura (AITP), Graves' disease and ovarian carcinoma. Nouv Rev Fr Hematol (1991) 0.84
[Elastinolytic protease in human blood platelets]. Atherosclerosis (1971) 0.84
Long-term efficacy and cost-effectiveness of polyethylene glycol 3350 plus electrolytes in chronic constipation: a retrospective study in a disabled population. Curr Med Res Opin (2006) 0.84
[Biotinidase deficiency. Progressive encephalopathy curable with biotin]. Arch Fr Pediatr (1993) 0.83
Discrimination between activity of (alpha 2-3)-sialyltransferase and (alpha 2-6)-sialyltransferase in human platelets using p-nitrophenyl-beta-D-galactoside as acceptor. Eur J Biochem (1982) 0.83
The thermostable β-1,3-1,4-glucanase from Clostridium thermocellum improves the nutritive value of highly viscous barley-based diets for broilers. Br Poult Sci (2012) 0.83
Culture of C3A cells in alginate beads for fluidized bed bioartificial liver. Transplant Proc (2007) 0.82
[Demonstration of DNA and polysaccharides using a new "Schiff type" reagent]. C R Acad Sci Hebd Seances Acad Sci D (1973) 0.82
[Blue tongue, a new disease of sheep in La Réunion (Indian Ocean)]. Rev Elev Med Vet Pays Trop (1985) 0.82
Inhibition of antithrombin by protein SV-IV normalizes the coagulation of hemophilic blood. Eur J Pharmacol (2000) 0.82
Hermansky-Pudlak platelets: further studies on release reaction and protein phosphorylations. Am J Hematol (1987) 0.82
[Demonstration and ultrastructure of hepatic glycogen. The effect of technics on the preparation]. J Ultrastruct Res (1966) 0.82
[Increasing trends in screening for addictives behaviors among general practitioners in France]. Rev Epidemiol Sante Publique (2011) 0.81
Thermotropic state transition in isolated platelet membranes studied by Raman spectroscopy. Eur J Biochem (1983) 0.81
Palliative radiotherapy in recurrent head-and-neck tumors by a percutaneous superfractionated treatment schedule. Int J Radiat Oncol Biol Phys (2001) 0.81
[Study of platelet functions in 7 cases of refractory anemia]. Nouv Rev Fr Hematol (1969) 0.81
Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet (1989) 0.81
[Evolutive study of the ultrastructure of megakaryocytes in a case of idiopathic thrombopenic purpura before, 12 days, and 5 months after splenectomy]. Blut (1969) 0.81
KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction. Eur J Biochem (1990) 0.81
[Purified collagens and blood platelets. (Effect of certain "osides" on platelet adhesion and aggregation)]. Nouv Rev Fr Hematol (1968) 0.81
Thrombospondin, a negative modulator of megakaryocytopoiesis. J Lab Clin Med (1997) 0.81
[Prolongation of bleeding time and collagen anomalies]. Nouv Rev Fr Hematol (1970) 0.81
[New outcome rates for random sampling telephone surveys]. Rev Epidemiol Sante Publique (2011) 0.81
Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia. Atherosclerosis (1989) 0.80
Cholesterol in acute cholestasis induced by taurolithocholic acid. A cytochemical study in transmission and scanning electron microscopy. Lab Invest (1978) 0.80
Alveolar macrophages from allergic lungs are not committed to a pro-allergic response and can reduce airway hyperresponsiveness following ex vivo culture. Clin Exp Allergy (2008) 0.80
[Study of cholangiogenesis in the human fetus. I. Ultrastructural aspects and classification of various epithelial cell types found in the periportal region]. Z Zellforsch Mikrosk Anat (1968) 0.80
Platelet surface glycoprotein changes in patients with cerebral ischemia. Nouv Rev Fr Hematol (1991) 0.80
Glycogen synthestase activity in blood platelets. Nature (1968) 0.80
Three-dimensional growth of human hepatoma C3A cells within alginate beads for fluidized bioartificial liver. Int J Artif Organs (2008) 0.80
PDGF modifies phosphoinositide metabolism and inhibits aggregation and release in human platelets. Biochem Biophys Res Commun (1986) 0.80
[Technic of blood pressure measurement in children]. Schweiz Rundsch Med Prax (1984) 0.79
[Unconjugated bilirubin pigment. Structure and ultrastructure of the renal papilla in the Gunn rat]. Pathol Eur (1972) 0.79
Severe proximal deep vein thrombosis in a Glanzmann thrombasthenia variant successfully treated with a low molecular weight heparin. Blood (1997) 0.79
Signal transduction in normal and pathological thrombin-stimulated human platelets. Biochimie (1987) 0.79
[Acquired Von Willebrand disease with chronic lymphocytic leukaemia and angiodysplasia (author's transl)]. Nouv Presse Med (1977) 0.79
[Changes in serum proteins and ultrastructure of thrombocytes in the Wiskott-Aldrich syndrome]. Cas Lek Cesk (1966) 0.79
[Platelet membrane glycoprotein defect, molecular basis for the abnormal adhesion of platelets to the subendothelium in thrombocytic hemorrhagic dystrophy]. C R Acad Sci Hebd Seances Acad Sci D (1975) 0.79
[Ultrastructure of the human liver in chronic idiopathic jaundice. IV. Mitochondria of unusual morphology and hepatocytic "paracrystalline cytoplasmic inclusions"]. Z Zellforsch Mikrosk Anat (1967) 0.79
Elastolytic protease in blood platelets. Ser Haematol (1971) 0.79
The defective prothrombin consumption in Bernard-Soulier syndrome. Hypotheses from 1948 to 1982. Blood Cells (1983) 0.79
Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium. J Lab Clin Med (1986) 0.79